|
|
||||||||
1 Laboratory of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578; and 2 Department of Dental Pharmacology, The Nippon Dental University School of Dentistry at Niigata, Niigata 951-8580, Japan
We elucidated the functional
contribution of voltage-dependent calcium channels (VDCCs) and
adenylate cyclase to epinephrine (Epi) and norepinephrine (NE)
secretion induced by pituitary adenylate cyclase-activating polypeptide
(PACAP) in the isolated perfused rat adrenal gland. PACAP increased Epi
and NE output, which was inhibited by perfusion with calcium-free
solution or by nifedipine, an L-type VDCC blocker. However, the
PACAP-induced responses were resistant to
-conotoxin GVIA, an N-type
VDCC blocker, or
-conotoxin MVIIC, a P/Q-type VDCC blocker.
MDL-12330A, an adenylate cyclase inhibitor, inhibited the PACAP-induced
increase in Epi, but not NE, output. Treatment with nifedipine and
MDL-12330A caused additive inhibition of the PACAP-induced
catecholamine responses. These results suggest that opening of L-type
VDCCs is responsible for adrenal catecholamine secretion induced by
PACAP and that activation of adenylate cyclase is involved in the
PACAP-induced Epi, but not NE, secretion. These pathways may act
independently of each other.
pituitary adenylate cyclase-activating polypeptide; nifedipine;
-conotoxin GVIA;
-conotoxin MVIIC; MDL-12330A
This article has been cited by other articles:
![]() |
D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, O. Wurtz, A. Fournier, B. K. C. Chow, H. Hashimoto, L. Galas, et al. Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery Pharmacol. Rev., September 1, 2009; 61(3): 283 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Skott Pituitary adenylate cyclase-activating polypeptide and adrenomedullary function Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R586 - R587. [Full Text] [PDF] |
||||
![]() |
K. Morita, A. Sakakibara, S. Kitayama, K. Kumagai, K. Tanne, and T. Dohi Pituitary Adenylate Cyclase-Activating Polypeptide Induces a Sustained Increase in Intracellular Free Ca2+ Concentration and Catecholamine Release by Activating Ca2+ Influx via Receptor-Stimulated Ca2+ Entry, Independent of Store-Operated Ca2+ Channels, and Voltage-Dependent Ca2+ Channels in Bovine Adrenal Medullary Chromaffin Cells J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 972 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gopalakrishnan, S. A. Buckner, I. Milicic, D. R. Groebe, K. L. Whiteaker, D. J. Burns, U. Warrior, and M. Gopalakrishnan Functional Characterization of Adenosine Receptors and Coupling to ATP-Sensitive K+ Channels in Guinea Pig Urinary Bladder Smooth Muscle J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 910 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fukushima, H. Hikichi, K. Mizukami, T. Nagayama, M. Yoshida, M. Suzuki-Kusaba, H. Hisa, T. Kimura, and S. Satoh Role of endogenous PACAP in catecholamine secretion from the rat adrenal gland Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1562 - R1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tanioka, K. Nakamura, S. Fujimura, M. Yoshida, M. Suzuki-Kusaba, H. Hisa, and S. Satoh Facilitatory role of NO in neural norepinephrine release in the rat kidney Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1436 - R1442. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |